Problem definition: We investigate the effectiveness of different Extended Producer Responsibility (EPR) implementation models for pharmaceuticals. In particular, we study two viable and prevalent models: (i) Source Reduction (SR), where a form of fee upon sale is imposed on producers, and (ii)...